Paul Conrad

Statistics

Publications

Citations

930

H-Index

Active since

1999

Affiliations

University of Cincinnati Medical Center(Current)

Joslin Diabetes Center

Jaeb Center for Health Research

University of Pennsylvania

Johns Hopkins Medicine

Paul Conrad is an author at University of Cincinnati Medical Center specializing in life sciences, hypoxia adaptation, and cellular responses to hypoxia.

Publications per year

1999–2024

Publications

Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials

Alex Willoughby, Gui‐Shuang Ying, Cynthia A. Toth et al. · Ophthalmology · 2015 · 212 citations · Full text

Medicine, Ophthalmology, Vision Science +12

Selective Activation of p38α and p38γ by Hypoxia

Paul Conrad, Randall T. Rust, Jiahuai Han et al. · Journal of Biological Chemistry · 1999 · 179 citations · Full text

Life Sciences, Biochemistry, Cell Biology +12

EPAS1 trans-Activation during Hypoxia Requires p42/p44 MAPK

Paul Conrad, Thomas L. Freeman, Dana Beitner‐Johnson et al. · Journal of Biological Chemistry · 1999 · 177 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial

David M. Brown, David S. Boyer, V. Diana et al. · The Lancet · 2024 · 113 citations

Health Professions, Ophthalmology, Pharmacotherapy +10

Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema

Lee M. Jampol, Adam R. Glassman, Danni Liu et al. · Ophthalmology · 2018 · 44 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +12

1–5 of 14